#JPM24: RTW, Bayer back Cytokinetics-allied Ji Xing Pharmaceuticals with $162M

SAN FRANCISCO — RTW Investments is once again providing funding to Ji Xing Pharmaceuticals, the Shanghai-based biotech it incubated in 2019, with $127 million alongside a $35 million investment from Bayer’s Leaps by Bayer unit.

The Series D financing, disclosed in the weekend leading up to…
Click here to view original post